Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
Partially Oriented Yarn (POY): Valued at US$ 31.76 billion in 2023, projected to grow to US$ 48.23 billion by 2030, CAGR 6.2%, driven by increasing downstream demand.
- Bonafide Trust
- 04-01-2024
- Pages : 155
- Figures : 83
- Tables : 181
- Region : Global
- Category : Lifescience
- Pharmaceutical
According to publisher, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biopharmaceuticals market.
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
Key Features:
The report on Biopharmaceuticals market reflects various aspects and provide valuable insights into the industry. The worldwide biopharmaceuticals showcase may be a flourishing segment at the bleeding edge of therapeutic advancement.
Market Measure and Development Trajectory
The biopharmaceuticals advertise is evaluated to be a multibillion dollar industry. It is measured at USD 437.12 billion in 2022, and estimates a noteworthy rise to USD 799.76 billion by 2030, reflecting a sound CAGR of 7.9.
Growth Drivers Fuelling the Market:
Rising Predominance of Constant Infections, The expanding burden of constant infections like cancer, diabetes, and cardiovascular afflictions is driving request for focused on biopharmaceutical treatments. For occurrence, the American Cancer Society gauges over 1.9 million modern cancer cases will be analyzed within the US alone in 2024 American Cancer Society Cancer Truths Figures 2024. Biopharmaceuticals offer promising treatment choices for such conditions.
Aging Populace The worldwide populace is maturing quickly, driving to a better predominance of age related illnesses. Biopharmaceuticals offer significant medicines for these conditions, impelling advertise growth.
Technological Progressions Breakthroughs in biotechnology, such as quality altering and quality treatment, are driving to the improvement of more exact and compelling biopharmaceuticals. For case, the improvement of CAR T cell treatment for certain cancers represents the control of these advancements.
Challenges and Openings Exploring the Landscape
High Investigate and Improvement Costs Creating biopharmaceuticals may be a complex and costly handle. Adjusting development with reasonableness remains a challenge.
Stringent Administrative Prerequisites Guaranteeing the security and viability of biopharmaceuticals requires strict controls, which can protract sedate advancement timelines.
Patent Expiries: The expiration of licenses on blockbuster drugs can lead to income decrease for pharmaceutical companies. In any case, this too makes openings for nonexclusive sedate manufacturers.
Examples of Key Players:
The biopharmaceutical advertise may be a competitive scene with built up players like Roche Switzerland, Johnson Johnson US, Merck Co. US, and AbbVie US at the cutting edge . These companies contribute intensely in investigate and advancement to bring imaginative biopharmaceuticals to market.
Future Viewpoint A Promising Horizon
The future of the biopharmaceuticals advertise looks shinning. Ceaseless progressions in investigate, developing government back, and rising healthcare use in developing economies will likely fuel assist advertise development. Personalized pharmaceutical and the integration of fake insights offer energizing conceivable outcomes for long-standing time of biopharmaceutical advancement.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Interferon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biopharmaceuticals industry. This include advancements in Biopharmaceuticals technology, Biopharmaceuticals new entrants, Biopharmaceuticals new investment, and other innovations that are shaping the future of Biopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Biopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biopharmaceuticals market.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Segmentation:
Biopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segmentation by application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
This report also splits the market by region: North America as of now leads the showcase due to solid investigate framework, tall healthcare investing, and the nearness of major biopharmaceutical companies like Pfizer and Amgen. Be that as it may, Asia Pacific is anticipated to witness the speediest development due to factors like government activities advancing biopharmaceutical advancement and an expansive understanding population.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira ?Pfizer?
MYLAN
Sun pharma
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Biopharmaceuticals Market Size 2019-2030
- 2.1.2 Biopharmaceuticals Market Size CAGR by Region 2019 VS 2023 VS 2030
- 2.2 Biopharmaceuticals Segment by Type
- 2.2.1 Monoclonal Antibodies
- 2.2.2 Interferon
- 2.2.3 Colony-Stimulating Factor
- 2.2.4 Erythropoietin
- 2.2.5 Insulin
- 2.2.6 Vaccines
- 2.2.7 Growth Hormones
- 2.2.8 Others
- 2.3 Biopharmaceuticals Market Size by Type
- 2.3.1 Biopharmaceuticals Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Biopharmaceuticals Market Size Market Share by Type (2019-2024)
- 2.4 Biopharmaceuticals Segment by Application
- 2.4.1 Tumor
- 2.4.2 Diabetes
- 2.4.3 Cardiovascular
- 2.4.4 Hemophilia
- 2.4.5 Others
- 2.5 Biopharmaceuticals Market Size by Application
- 2.5.1 Biopharmaceuticals Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Biopharmaceuticals Market Size Market Share by Application (2019-2024)
- 3 Biopharmaceuticals Market Size by Player
- 3.1 Biopharmaceuticals Market Size Market Share by Players
- 3.1.1 Global Biopharmaceuticals Revenue by Players (2019-2024)
- 3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2019-2024)
- 3.2 Global Biopharmaceuticals Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Biopharmaceuticals by Regions
- 4.1 Biopharmaceuticals Market Size by Regions (2019-2024)
- 4.2 Americas Biopharmaceuticals Market Size Growth (2019-2024)
- 4.3 APAC Biopharmaceuticals Market Size Growth (2019-2024)
- 4.4 Europe Biopharmaceuticals Market Size Growth (2019-2024)
- 4.5 Middle East & Africa Biopharmaceuticals Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Biopharmaceuticals Market Size by Country (2019-2024)
- 5.2 Americas Biopharmaceuticals Market Size by Type (2019-2024)
- 5.3 Americas Biopharmaceuticals Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Biopharmaceuticals Market Size by Region (2019-2024)
- 6.2 APAC Biopharmaceuticals Market Size by Type (2019-2024)
- 6.3 APAC Biopharmaceuticals Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Biopharmaceuticals by Country (2019-2024)
- 7.2 Europe Biopharmaceuticals Market Size by Type (2019-2024)
- 7.3 Europe Biopharmaceuticals Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Biopharmaceuticals by Region (2019-2024)
- 8.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Biopharmaceuticals Market Forecast
- 10.1 Global Biopharmaceuticals Forecast by Regions (2025-2030)
- 10.1.1 Global Biopharmaceuticals Forecast by Regions (2025-2030)
- 10.1.2 Americas Biopharmaceuticals Forecast
- 10.1.3 APAC Biopharmaceuticals Forecast
- 10.1.4 Europe Biopharmaceuticals Forecast
- 10.1.5 Middle East & Africa Biopharmaceuticals Forecast
- 10.2 Americas Biopharmaceuticals Forecast by Country (2025-2030)
- 10.2.1 United States Biopharmaceuticals Market Forecast
- 10.2.2 Canada Biopharmaceuticals Market Forecast
- 10.2.3 Mexico Biopharmaceuticals Market Forecast
- 10.2.4 Brazil Biopharmaceuticals Market Forecast
- 10.3 APAC Biopharmaceuticals Forecast by Region (2025-2030)
- 10.3.1 China Biopharmaceuticals Market Forecast
- 10.3.2 Japan Biopharmaceuticals Market Forecast
- 10.3.3 Korea Biopharmaceuticals Market Forecast
- 10.3.4 Southeast Asia Biopharmaceuticals Market Forecast
- 10.3.5 India Biopharmaceuticals Market Forecast
- 10.3.6 Australia Biopharmaceuticals Market Forecast
- 10.4 Europe Biopharmaceuticals Forecast by Country (2025-2030)
- 10.4.1 Germany Biopharmaceuticals Market Forecast
- 10.4.2 France Biopharmaceuticals Market Forecast
- 10.4.3 UK Biopharmaceuticals Market Forecast
- 10.4.4 Italy Biopharmaceuticals Market Forecast
- 10.4.5 Russia Biopharmaceuticals Market Forecast
- 10.5 Middle East & Africa Biopharmaceuticals Forecast by Region (2025-2030)
- 10.5.1 Egypt Biopharmaceuticals Market Forecast
- 10.5.2 South Africa Biopharmaceuticals Market Forecast
- 10.5.3 Israel Biopharmaceuticals Market Forecast
- 10.5.4 Turkey Biopharmaceuticals Market Forecast
- 10.5.5 GCC Countries Biopharmaceuticals Market Forecast
- 10.6 Global Biopharmaceuticals Forecast by Type (2025-2030)
- 10.7 Global Biopharmaceuticals Forecast by Application (2025-2030)
- 11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Roche Company Information
- 11.1.2 Roche Biopharmaceuticals Product Offered
- 11.1.3 Roche Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Roche Main Business Overview
- 11.1.5 Roche Latest Developments
- 11.2 Amgen
- 11.2.1 Amgen Company Information
- 11.2.2 Amgen Biopharmaceuticals Product Offered
- 11.2.3 Amgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 Amgen Main Business Overview
- 11.2.5 Amgen Latest Developments
- 11.3 AbbVie
- 11.3.1 AbbVie Company Information
- 11.3.2 AbbVie Biopharmaceuticals Product Offered
- 11.3.3 AbbVie Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 AbbVie Main Business Overview
- 11.3.5 AbbVie Latest Developments
- 11.4 Sanofi-Aventis
- 11.4.1 Sanofi-Aventis Company Information
- 11.4.2 Sanofi-Aventis Biopharmaceuticals Product Offered
- 11.4.3 Sanofi-Aventis Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 Sanofi-Aventis Main Business Overview
- 11.4.5 Sanofi-Aventis Latest Developments
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Company Information
- 11.5.2 Johnson & Johnson Biopharmaceuticals Product Offered
- 11.5.3 Johnson & Johnson Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 Johnson & Johnson Main Business Overview
- 11.5.5 Johnson & Johnson Latest Developments
- 11.6 Pfizer
- 11.6.1 Pfizer Company Information
- 11.6.2 Pfizer Biopharmaceuticals Product Offered
- 11.6.3 Pfizer Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 Pfizer Main Business Overview
- 11.6.5 Pfizer Latest Developments
- 11.7 Novo Nordisk
- 11.7.1 Novo Nordisk Company Information
- 11.7.2 Novo Nordisk Biopharmaceuticals Product Offered
- 11.7.3 Novo Nordisk Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 Novo Nordisk Main Business Overview
- 11.7.5 Novo Nordisk Latest Developments
- 11.8 Eli Lilly
- 11.8.1 Eli Lilly Company Information
- 11.8.2 Eli Lilly Biopharmaceuticals Product Offered
- 11.8.3 Eli Lilly Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 Eli Lilly Main Business Overview
- 11.8.5 Eli Lilly Latest Developments
- 11.9 Novartis
- 11.9.1 Novartis Company Information
- 11.9.2 Novartis Biopharmaceuticals Product Offered
- 11.9.3 Novartis Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Novartis Main Business Overview
- 11.9.5 Novartis Latest Developments
- 11.10 Merck
- 11.10.1 Merck Company Information
- 11.10.2 Merck Biopharmaceuticals Product Offered
- 11.10.3 Merck Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 Merck Main Business Overview
- 11.10.5 Merck Latest Developments
- 11.11 Sun
- 11.11.1 Sun Company Information
- 11.11.2 Sun Biopharmaceuticals Product Offered
- 11.11.3 Sun Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 Sun Main Business Overview
- 11.11.5 Sun Latest Developments
- 11.12 3sbio
- 11.12.1 3sbio Company Information
- 11.12.2 3sbio Biopharmaceuticals Product Offered
- 11.12.3 3sbio Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 3sbio Main Business Overview
- 11.12.5 3sbio Latest Developments
- 11.13 Changchun High Tech
- 11.13.1 Changchun High Tech Company Information
- 11.13.2 Changchun High Tech Biopharmaceuticals Product Offered
- 11.13.3 Changchun High Tech Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 Changchun High Tech Main Business Overview
- 11.13.5 Changchun High Tech Latest Developments
- 11.14 CP Guojian
- 11.14.1 CP Guojian Company Information
- 11.14.2 CP Guojian Biopharmaceuticals Product Offered
- 11.14.3 CP Guojian Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.14.4 CP Guojian Main Business Overview
- 11.14.5 CP Guojian Latest Developments
- 11.15 Biotech
- 11.15.1 Biotech Company Information
- 11.15.2 Biotech Biopharmaceuticals Product Offered
- 11.15.3 Biotech Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.15.4 Biotech Main Business Overview
- 11.15.5 Biotech Latest Developments
- 11.16 Gelgen
- 11.16.1 Gelgen Company Information
- 11.16.2 Gelgen Biopharmaceuticals Product Offered
- 11.16.3 Gelgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.16.4 Gelgen Main Business Overview
- 11.16.5 Gelgen Latest Developments
- 11.17 Innovent
- 11.17.1 Innovent Company Information
- 11.17.2 Innovent Biopharmaceuticals Product Offered
- 11.17.3 Innovent Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.17.4 Innovent Main Business Overview
- 11.17.5 Innovent Latest Developments
- 11.18 Dong Bao
- 11.18.1 Dong Bao Company Information
- 11.18.2 Dong Bao Biopharmaceuticals Product Offered
- 11.18.3 Dong Bao Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.18.4 Dong Bao Main Business Overview
- 11.18.5 Dong Bao Latest Developments
- 11.19 Ganlee
- 11.19.1 Ganlee Company Information
- 11.19.2 Ganlee Biopharmaceuticals Product Offered
- 11.19.3 Ganlee Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.19.4 Ganlee Main Business Overview
- 11.19.5 Ganlee Latest Developments
- 11.20 United Laboratories
- 11.20.1 United Laboratories Company Information
- 11.20.2 United Laboratories Biopharmaceuticals Product Offered
- 11.20.3 United Laboratories Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.20.4 United Laboratories Main Business Overview
- 11.20.5 United Laboratories Latest Developments
- 11.21 SANDOZ (NOVARTIS)
- 11.21.1 SANDOZ (NOVARTIS) Company Information
- 11.21.2 SANDOZ (NOVARTIS) Biopharmaceuticals Product Offered
- 11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.21.4 SANDOZ (NOVARTIS) Main Business Overview
- 11.21.5 SANDOZ (NOVARTIS) Latest Developments
- 11.22 Teva Pharmaceutical
- 11.22.1 Teva Pharmaceutical Company Information
- 11.22.2 Teva Pharmaceutical Biopharmaceuticals Product Offered
- 11.22.3 Teva Pharmaceutical Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.22.4 Teva Pharmaceutical Main Business Overview
- 11.22.5 Teva Pharmaceutical Latest Developments
- 11.23 Hospira ?Pfizer?
- 11.23.1 Hospira ?Pfizer? Company Information
- 11.23.2 Hospira ?Pfizer? Biopharmaceuticals Product Offered
- 11.23.3 Hospira ?Pfizer? Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.23.4 Hospira ?Pfizer? Main Business Overview
- 11.23.5 Hospira ?Pfizer? Latest Developments
- 11.24 MYLAN
- 11.24.1 MYLAN Company Information
- 11.24.2 MYLAN Biopharmaceuticals Product Offered
- 11.24.3 MYLAN Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.24.4 MYLAN Main Business Overview
- 11.24.5 MYLAN Latest Developments
- 11.25 Sun pharma
- 11.25.1 Sun pharma Company Information
- 11.25.2 Sun pharma Biopharmaceuticals Product Offered
- 11.25.3 Sun pharma Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
- 11.25.4 Sun pharma Main Business Overview
- 11.25.5 Sun pharma Latest Developments
- 12 Research Findings and Conclusion
Table 1. Biopharmaceuticals Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Colony-Stimulating Factor
Table 5. Major Players of Erythropoietin
Table 6. Major Players of Insulin
Table 7. Major Players of Vaccines
Table 8. Major Players of Growth Hormones
Table 9. Major Players of Others
Table 10. Biopharmaceuticals Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biopharmaceuticals Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Biopharmaceuticals Market Size Market Share by Type (2019-2024)
Table 13. Biopharmaceuticals Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Biopharmaceuticals Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Biopharmaceuticals Market Size Market Share by Application (2019-2024)
Table 16. Global Biopharmaceuticals Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Biopharmaceuticals Revenue Market Share by Player (2019-2024)
Table 18. Biopharmaceuticals Key Players Head office and Products Offered
Table 19. Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Biopharmaceuticals Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Biopharmaceuticals Market Size Market Share by Regions (2019-2024)
Table 24. Global Biopharmaceuticals Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Biopharmaceuticals Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Biopharmaceuticals Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Biopharmaceuticals Market Size Market Share by Country (2019-2024)
Table 28. Americas Biopharmaceuticals Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Biopharmaceuticals Market Size Market Share by Type (2019-2024)
Table 30. Americas Biopharmaceuticals Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Biopharmaceuticals Market Size Market Share by Application (2019-2024)
Table 32. APAC Biopharmaceuticals Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Biopharmaceuticals Market Size Market Share by Region (2019-2024)
Table 34. APAC Biopharmaceuticals Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Biopharmaceuticals Market Size Market Share by Type (2019-2024)
Table 36. APAC Biopharmaceuticals Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Biopharmaceuticals Market Size Market Share by Application (2019-2024)
Table 38. Europe Biopharmaceuticals Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Biopharmaceuticals Market Size Market Share by Country (2019-2024)
Table 40. Europe Biopharmaceuticals Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Biopharmaceuticals Market Size Market Share by Type (2019-2024)
Table 42. Europe Biopharmaceuticals Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Biopharmaceuticals Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Biopharmaceuticals Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Biopharmaceuticals Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Biopharmaceuticals Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Biopharmaceuticals Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Biopharmaceuticals Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Biopharmaceuticals Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Biopharmaceuticals
Table 51. Key Market Challenges & Risks of Biopharmaceuticals
Table 52. Key Industry Trends of Biopharmaceuticals
Table 53. Global Biopharmaceuticals Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Biopharmaceuticals Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Biopharmaceuticals Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Biopharmaceuticals Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Roche Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 58. Roche Biopharmaceuticals Product Offered
Table 59. Roche Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Roche Main Business
Table 61. Roche Latest Developments
Table 62. Amgen Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 63. Amgen Biopharmaceuticals Product Offered
Table 64. Amgen Main Business
Table 65. Amgen Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Amgen Latest Developments
Table 67. AbbVie Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 68. AbbVie Biopharmaceuticals Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. AbbVie Latest Developments
Table 72. Sanofi-Aventis Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 73. Sanofi-Aventis Biopharmaceuticals Product Offered
Table 74. Sanofi-Aventis Main Business
Table 75. Sanofi-Aventis Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sanofi-Aventis Latest Developments
Table 77. Johnson & Johnson Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 78. Johnson & Johnson Biopharmaceuticals Product Offered
Table 79. Johnson & Johnson Main Business
Table 80. Johnson & Johnson Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Johnson & Johnson Latest Developments
Table 82. Pfizer Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 83. Pfizer Biopharmaceuticals Product Offered
Table 84. Pfizer Main Business
Table 85. Pfizer Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Pfizer Latest Developments
Table 87. Novo Nordisk Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 88. Novo Nordisk Biopharmaceuticals Product Offered
Table 89. Novo Nordisk Main Business
Table 90. Novo Nordisk Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Novo Nordisk Latest Developments
Table 92. Eli Lilly Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 93. Eli Lilly Biopharmaceuticals Product Offered
Table 94. Eli Lilly Main Business
Table 95. Eli Lilly Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Eli Lilly Latest Developments
Table 97. Novartis Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 98. Novartis Biopharmaceuticals Product Offered
Table 99. Novartis Main Business
Table 100. Novartis Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Novartis Latest Developments
Table 102. Merck Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 103. Merck Biopharmaceuticals Product Offered
Table 104. Merck Main Business
Table 105. Merck Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Merck Latest Developments
Table 107. Sun Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 108. Sun Biopharmaceuticals Product Offered
Table 109. Sun Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Sun Main Business
Table 111. Sun Latest Developments
Table 112. 3sbio Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 113. 3sbio Biopharmaceuticals Product Offered
Table 114. 3sbio Main Business
Table 115. 3sbio Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. 3sbio Latest Developments
Table 117. Changchun High Tech Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 118. Changchun High Tech Biopharmaceuticals Product Offered
Table 119. Changchun High Tech Main Business
Table 120. Changchun High Tech Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Changchun High Tech Latest Developments
Table 122. CP Guojian Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 123. CP Guojian Biopharmaceuticals Product Offered
Table 124. CP Guojian Main Business
Table 125. CP Guojian Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. CP Guojian Latest Developments
Table 127. Biotech Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 128. Biotech Biopharmaceuticals Product Offered
Table 129. Biotech Main Business
Table 130. Biotech Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Biotech Latest Developments
Table 132. Gelgen Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 133. Gelgen Biopharmaceuticals Product Offered
Table 134. Gelgen Main Business
Table 135. Gelgen Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Gelgen Latest Developments
Table 137. Innovent Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 138. Innovent Biopharmaceuticals Product Offered
Table 139. Innovent Main Business
Table 140. Innovent Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Innovent Latest Developments
Table 142. Dong Bao Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 143. Dong Bao Biopharmaceuticals Product Offered
Table 144. Dong Bao Main Business
Table 145. Dong Bao Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Dong Bao Latest Developments
Table 147. Ganlee Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 148. Ganlee Biopharmaceuticals Product Offered
Table 149. Ganlee Main Business
Table 150. Ganlee Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Ganlee Latest Developments
Table 152. United Laboratories Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 153. United Laboratories Biopharmaceuticals Product Offered
Table 154. United Laboratories Main Business
Table 155. United Laboratories Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. United Laboratories Latest Developments
Table 157. SANDOZ (NOVARTIS) Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 158. SANDOZ (NOVARTIS) Biopharmaceuticals Product Offered
Table 159. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 160. SANDOZ (NOVARTIS) Main Business
Table 161. SANDOZ (NOVARTIS) Latest Developments
Table 162. Teva Pharmaceutical Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 163. Teva Pharmaceutical Biopharmaceuticals Product Offered
Table 164. Teva Pharmaceutical Main Business
Table 165. Teva Pharmaceutical Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. Teva Pharmaceutical Latest Developments
Table 167. Hospira ?Pfizer? Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 168. Hospira ?Pfizer? Biopharmaceuticals Product Offered
Table 169. Hospira ?Pfizer? Main Business
Table 170. Hospira ?Pfizer? Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. Hospira ?Pfizer? Latest Developments
Table 172. MYLAN Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 173. MYLAN Biopharmaceuticals Product Offered
Table 174. MYLAN Main Business
Table 175. MYLAN Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. MYLAN Latest Developments
Table 177. Sun pharma Details, Company Type, Biopharmaceuticals Area Served and Its Competitors
Table 178. Sun pharma Biopharmaceuticals Product Offered
Table 179. Sun pharma Main Business
Table 180. Sun pharma Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 181. Sun pharma Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (26 December, 2024)
- Notify To Team (26 December, 2024)
- Report updation (27 December, 2024)
- Report Quality Check (27 December, 2024)
- Report Dispatch (28 December, 2024)
- Hard Copy
Recently Viewed Products
Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
We are friendly and approachable, give us a call.